Nukleus Office Solutions board meets Aug 29 to approve ESOP scheme
- Board meeting scheduled for August 29, 2026, to consider ESOP Scheme-I 2026
- Draft notice for General Meeting to be approved for shareholder consent
- Trading window closed for insiders until 48 hours post-meeting
- Compliance with SEBI Listing Obligations Regulations cited in intimation

*this image is generated using AI for illustrative purposes only.
Nukleus Office Solutions will hold a board meeting on Saturday, August 29, 2026, to consider the approval of its Employee Stock Option Plan for 2026.
The company informed BSE Limited on August 24, 2026, that the Board of Directors will deliberate on key corporate governance matters. The primary agenda includes formulating and approving the Nukleus Office Solutions Limited ESOP Scheme-I 2026. This action is subject to subsequent shareholder and regulatory approvals.
Meeting Agenda
The board will also approve the draft notice for the General Meeting required to seek necessary shareholder consents. Any other business items may be discussed with the permission of the Chair.
Insider Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the company's securities remains closed. This restriction applies to all Designated Persons and their immediate relatives until 48 hours after the conclusion of the scheduled board meeting.
Historical Stock Returns for Nukleus Office solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | -0.50% | +3.44% | +30.59% | +6.31% |
What is the total number of options allocated under the ESOP Scheme-I 2026, and how might this dilute existing shareholder equity?
Which key executives or departments are eligible for these stock options, and what performance metrics will determine vesting?
How does the proposed exercise price compare to the current market price of Nukleus Office Solutions shares?


































